CD39 deletion in TCR-engineered T cells enhances antitumour immunity.
作者信息
Tsai Alexander K, Stromnes Ingunn M
机构信息
Microbiology & Immunology, University of Minnesota, Minneapolis, Minnesota, USA.
Microbiology & Immunology, University of Minnesota, Minneapolis, Minnesota, USA
出版信息
Gut. 2024 Apr 5;73(5):716-717. doi: 10.1136/gutjnl-2023-330424.
Abstract
摘要
相似文献
1
CD39 deletion in TCR-engineered T cells enhances antitumour immunity.T细胞受体工程化T细胞中的CD39缺失增强抗肿瘤免疫力。
Gut. 2024 Apr 5;73(5):716-717. doi: 10.1136/gutjnl-2023-330424.
2
The CD39 HBV surface protein-targeted CAR-T and personalized tumor-reactive CD8 T cells exhibit potent anti-HCC activity.靶向 CD39HBV 表面蛋白的 CAR-T 和个体化肿瘤反应性 CD8 T 细胞显示出强大的抗 HCC 活性。
Mol Ther. 2021 May 5;29(5):1794-1807. doi: 10.1016/j.ymthe.2021.01.021. Epub 2021 Jan 21.
3
Co-expression of CD39 and CD103 identifies tumor-reactive CD8 T cells in human solid tumors.CD39 和 CD103 的共表达鉴定了人类实体瘤中肿瘤反应性 CD8 T 细胞。
Nat Commun. 2018 Jul 13;9(1):2724. doi: 10.1038/s41467-018-05072-0.
4
Revealing and harnessing CD39 for the treatment of colorectal cancer and liver metastases by engineered T cells.通过工程化 T 细胞揭示和利用 CD39 治疗结直肠癌和肝转移。
Gut. 2023 Oct;72(10):1887-1903. doi: 10.1136/gutjnl-2022-328042. Epub 2023 Jun 30.
5
CD39 Regulation and Functions in T Cells.CD39 的调控与 T 细胞功能
Int J Mol Sci. 2021 Jul 28;22(15):8068. doi: 10.3390/ijms22158068.
6
Expression of CD39 is associated with T cell exhaustion in ovarian cancer and its blockade reverts T cell dysfunction.CD39 的表达与卵巢癌中 T 细胞耗竭相关，其阻断可恢复 T 细胞功能障碍。
Oncoimmunology. 2024 May 9;13(1):2346359. doi: 10.1080/2162402X.2024.2346359. eCollection 2024.
7
CD39 Expression Defines Cell Exhaustion in Tumor-Infiltrating CD8 T Cells.CD39 表达定义了肿瘤浸润 CD8 T 细胞中的细胞耗竭。
Cancer Res. 2018 Jan 1;78(1):115-128. doi: 10.1158/0008-5472.CAN-16-2684. Epub 2017 Oct 24.
8
CD39 is highly involved in mediating the suppression activity of tumor-infiltrating CD8+ T regulatory lymphocytes.CD39 高度参与调节肿瘤浸润 CD8+T 调节性淋巴细胞的抑制活性。
Cancer Immunol Immunother. 2013 May;62(5):851-62. doi: 10.1007/s00262-013-1392-z. Epub 2013 Jan 29.
9
CD106 in Tumor-Specific Exhausted CD8+ T Cells Mediates Immunosuppression by Inhibiting TCR Signaling.肿瘤特异性耗竭 CD8+T 细胞中的 CD106 通过抑制 TCR 信号传递来介导免疫抑制。
Cancer Res. 2024 Jul 2;84(13):2109-2122. doi: 10.1158/0008-5472.CAN-23-0453.
10
CD39 is upregulated during activation of mouse and human T cells and attenuates the immune response to Listeria monocytogenes.CD39 在小鼠和人 T 细胞的激活过程中上调，并减弱对李斯特菌的免疫反应。
PLoS One. 2018 May 9;13(5):e0197151. doi: 10.1371/journal.pone.0197151. eCollection 2018.
引用本文的文献
1
Integrating Single-Cell RNA-Seq and ATAC-Seq Analysis Reveals Uterine Cell Heterogeneity and Regulatory Networks Linked to Pimpled Eggs in Chickens.整合单细胞RNA测序和转座酶可及染色质测序分析揭示鸡子宫细胞异质性及与丘疹蛋相关的调控网络。
Int J Mol Sci. 2024 Dec 15;25(24):13431. doi: 10.3390/ijms252413431.
本文引用的文献
1
Revealing and harnessing CD39 for the treatment of colorectal cancer and liver metastases by engineered T cells.通过工程化 T 细胞揭示和利用 CD39 治疗结直肠癌和肝转移。
Gut. 2023 Oct;72(10):1887-1903. doi: 10.1136/gutjnl-2022-328042. Epub 2023 Jun 30.
2
The ectonucleotidase CD39 identifies tumor-reactive CD8 T cells predictive of immune checkpoint blockade efficacy in human lung cancer.细胞外核苷酸酶 CD39 鉴定出预测人类肺癌免疫检查点阻断疗效的肿瘤反应性 CD8 T 细胞。
Immunity. 2023 Jan 10;56(1):93-106.e6. doi: 10.1016/j.immuni.2022.12.001. Epub 2022 Dec 26.
3
ATP and Adenosine Metabolism in Cancer: Exploitation for Therapeutic Gain.癌症中的 ATP 和腺苷代谢：治疗增益的探索。
Pharmacol Rev. 2022 Jul;74(3):797-822. doi: 10.1124/pharmrev.121.000528.
4
Mechanisms Governing Immunotherapy Resistance in Pancreatic Ductal Adenocarcinoma.调控胰腺导管腺癌免疫治疗抵抗的机制。
Front Immunol. 2021 Jan 28;11:613815. doi: 10.3389/fimmu.2020.613815. eCollection 2020.
5
Stem-like CD8 T cells mediate response of adoptive cell immunotherapy against human cancer.类干细胞 CD8 T 细胞介导过继性细胞免疫疗法对人类癌症的反应。
Science. 2020 Dec 11;370(6522):1328-1334. doi: 10.1126/science.abb9847.
6
Targeting CD39 in cancer.针对癌症的 CD39 靶点。
Nat Rev Immunol. 2020 Dec;20(12):739-755. doi: 10.1038/s41577-020-0376-4. Epub 2020 Jul 29.
7
Genetically driven CD39 expression shapes human tumor-infiltrating CD8 T-cell functions.基因驱动的CD39表达塑造人类肿瘤浸润性CD8 T细胞功能。
Int J Cancer. 2020 Nov 1;147(9):2597-2610. doi: 10.1002/ijc.33131. Epub 2020 Jul 8.
8
Developmental Relationships of Four Exhausted CD8 T Cell Subsets Reveals Underlying Transcriptional and Epigenetic Landscape Control Mechanisms.四种耗竭 CD8 T 细胞亚群的发育关系揭示了潜在的转录和表观遗传调控机制。
Immunity. 2020 May 19;52(5):825-841.e8. doi: 10.1016/j.immuni.2020.04.014. Epub 2020 May 11.
9
TOX is a critical regulator of tumour-specific T cell differentiation.TOX 是肿瘤特异性 T 细胞分化的关键调节因子。
Nature. 2019 Jul;571(7764):270-274. doi: 10.1038/s41586-019-1324-y. Epub 2019 Jun 17.
10
Bystander CD8 T cells are abundant and phenotypically distinct in human tumour infiltrates.在人类肿瘤浸润物中，旁观者 CD8 T 细胞丰富且表型独特。
Nature. 2018 May;557(7706):575-579. doi: 10.1038/s41586-018-0130-2. Epub 2018 May 16.
Zotero 插件